Composition for suppressing muscular atrophy
The present invention provides a composition for suppressing muscular atrophy, comprising as an active ingredient(s) one or more peptides selected from the group consisting of tripeptides DIY, IYN, YNP, NPQ, DFY, DIF, FYN, IFN, FNP, and NPK; the group consisting of dipeptides comprising F; and the group consisting of dipeptides DI, IY, YN, and NP.
1. A method for suppressing muscular atrophy, comprising administering to a subject in need thereof one or more peptides selected from
the group consisting of tripeptides DIY, IYN, YNP, NPQ, DFY, DIF, FYN, IFN, FNP, and NPK; and
the group consisting of dipeptides DI, IF, FN, FY, IY, YN, and NP.
2. The method according to claim 1 , wherein the one or more peptides comprise FN.
3. The method according to claim 1 , for treating a disease with muscular atrophy.
4. The method according to claim 3 , wherein the disease is sarcopenia, disuse muscle atrophy, muscular dystrophy, diabetic amyotrophy, cachexia, steroid myopathy, drug induced myopathy, rhabdomyolysis, myasthenia gravis, amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, or stress urinary incontinence.
5. The method according to claim 1 , wherein the one or more peptides are comprised in a pharmaceutical product.
6. The method according to claim 1 , wherein the one or more peptides are included in a food or drink.
7. A method for improving low muscle mass, comprising administering to a subject in need thereof one or more peptides selected from
the group consisting of tripeptides DIY, IYN, YNP, NPQ, DFY, DIF, FYN, IFN, FNP, and NPK; and
the group consisting of dipeptides DI, IF, FN, FY, IY, YN, and NP.
8. The method according to claim 7 , wherein the one or more peptides comprise FN.
9. The method according to claim 7 , for improving stress urinary incontinence.
10. The method according to claim 7 , for improving urine leakage.
11. The method according to claim 7 , wherein the one or more peptides are comprised in a food or drink.